Andy Lundin, Author at Hematology Advancements

Customized Care Plans for Hemophilia: Integrating Patient-Specific Therapies

Posted by Andy Lundin | Jun 12, 2024 | Patient Management |

Personalized care plans for hemophilia, featuring innovative therapies like gene therapy, significantly enhance patient outcomes.

Posted by Andy Lundin | Jun 12, 2024 | Case Studies |

Early diagnosis and a multidisciplinary approach are crucial in managing complex coagulopathies like DIC and TTP in critical care.

AML immunotherapy treatment includes CAR-T cell therapy, bispecific T-cell engagers, checkpoint inhibitors, and antibody-based therapies.

Posted by Andy Lundin | Jun 11, 2024 | Clinical Practice |

Personalized medicine offers tailored therapies for lymphoma based on the genetic and molecular profiles of individual patients.

Posted by Andy Lundin | Jun 11, 2024 | AI in Hematology |

AI enhances diagnostic accuracy in hematology via AI-assisted flow cytometry, rapid complete blood counts and improved leukemia diagnostics.